Press release
Chemotherapy-Induced Anemia Global Market Analysis, Trends, Growth, Research And Forecast 2033
Chemotherapy-Induced Anemia Global Market
The Business Research Company offers in-depth market insights through Chemotherapy-Induced Anemia Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The chemotherapy-induced anemia market size has grown strongly in recent years. It will grow from $2.4 billion in 2023 to $2.6 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased prevalence of cancer and chemotherapy treatments, aging population leading to higher cancer incidence, expansion of chemotherapy drugs and regimens, improvement in overall cancer survival rates, awareness and diagnosis of anemia as a side effect
.
The chemotherapy-induced anemia market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to development of supportive care in oncology, rise in healthcare expenditure and infrastructure, personalized medicine and targeted cancer therapies, integration of biomarker-driven treatment approaches, increasing focus on early detection and intervention, integration of digital health technologies in patient management. Major trends in the forecast period include innovation of novel chemotherapy agents, integration of ml, advancements in cancer research and treatment protocols, integration of ai, collaboration between pharmaceutical companies and healthcare providers.
Get Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11967&type=smp
Market Segmentation:
The chemotherapy-induced anemia market covered in this report is segmented -
1) By Anemia: Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia
2) By Treatment Type: RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Multispecialty Clinics, Cancer Research Centers,Cancer Rehabilitation Centers
Major Driver - Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Market
The high prevalence of cancer and anemia is expected to propel the growth of the chemotherapy-induced anemia market going forward. Cancer is a disease where somebody's cells grow out of control and spread to other body regions. In cancer patients receiving aggressive chemotherapy, whether with or without radiation therapy, cancer and chemotherapy-induced anemia (CIA) are frequent occurrences. The medication stimulates the production of red blood cells in the bone marrow and can be used to treat chemotherapy-induced anemia. For instance, in 2023, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence of head and neck cancer in the UK is projected to rise by 3% between 2023 and 2025, while deaths due to head and neck cancers are expected to increase by 12% between 2023 and 2025. Therefore, the high prevalence of cancer and anemia drives the growth of the chemotherapy-induced anemia market.
Competitive Landscape:
Major companies operating in the chemotherapy-induced anemia market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Hospira Inc., Dr. Reddy's Laboratories Ltd., Biocon Ltd., 3SBio Group, FibroGen Inc., Karger AG, Avesthagen Ltd., Blausen Medical Communications Inc., Aileron Therapeutics Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report
Top Trend - Innovative Therapy For Extensive-Stage Small Cell Lung Cancer
Major companies in the chemotherapy-induced anemia market are focused on developing innovative therapy, such as myeloprotection therapy, for extensive-stage small cell lung cancer and to gain a competitive edge in the market. Myeloprotection therapy is a medical approach aimed at safeguarding bone marrow from damage caused by chemotherapy, reducing associated complications. For instance, in February 2021, G1 Therapeutics Inc., a US-based biopharmaceutical company, received FDA approval for COSELA (trilaciclib), the first myeloprotection therapy designed to reduce chemotherapy-induced myelosuppression, a condition characterized by a reduction in blood cell production in the bone marrow, and it can lead to complications such as neutropenia, anemia, and thrombocytopenia in patients with extensive-stage small-cell lung cancer. Administered before chemotherapy, COSELA protects bone marrow, reducing severe neutropenia incidence and duration. It offers multilineage protection, impacting anemia and the need for rescue interventions.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chemotherapy-Induced Anemia Market Characteristics
3. Chemotherapy-Induced Anemia Market Trends And Strategies
4. Chemotherapy-Induced Anemia Market - Macro Economic Scenario
5. Chemotherapy-Induced Anemia Market Size And Growth
…..
27. Chemotherapy-Induced Anemia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy-Induced Anemia Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3384803 • Views: …
More Releases from The Business research company
Future Prospects: Key Factors Shaping the Edge Print Servers for Data Centers Ma …
The edge print servers for data centers (DCs) market is poised for significant expansion as digital transformation and advanced printing needs rise across industries. With increasing reliance on edge computing and efficient print management, this market is set to experience rapid growth and technological innovation in the years ahead. Here is a detailed look at the market size, key players, segmentation, and emerging trends shaping this dynamic landscape.
Projected Market Growth…
Future Prospects: Key Factors Shaping the Edge Print Servers for Data Centers Ma …
The edge print servers for data centers (DCs) market is poised for significant expansion as digital transformation and advanced printing needs rise across industries. With increasing reliance on edge computing and efficient print management, this market is set to experience rapid growth and technological innovation in the years ahead. Here is a detailed look at the market size, key players, segmentation, and emerging trends shaping this dynamic landscape.
Projected Market Growth…
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented.
Direct Coombs Test (DCT) Antibody Market Size…
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential.
Projected Market Size and Growth for Dental Practice Analytics Dashboards
The market for dental practice analytics dashboards is…
More Releases for Anemia
Chemotherapy-Induced Anemia Market Forecast by Type Mild Moderate Severe and Lif …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition…
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period?
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435
This latest report researches the industry structure,…
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022
Global Anemia Drugs Market - Segments
Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;…
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,…
